Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Endocrine - Metabolic drug development
Diabetes - Metabolic Clinical Research
request info
First Name*:
Last Name*:
Leave a Message:

Please enter the security code

Find out how our medical, regulatory, and operational expertise in metabolic clinical development can help with your next study or program.

Learn More

"We are pleased to align ourselves with this industry leader [Medpace] who is known to implement best practices. We look forward to beginning FDA clinical trials on our oral insulin candidate with this award-winning CRO."

CEO of global pharmaceutical company

Endocrine and Metabolic CRO for Clinical Research

With a successful track record of approvable NDA submissions, deep therapeutic expertise and more than 20 years of experience, Medpace successfully navigates the complexities and regulatory scrutiny of endocrine/metabolic development programs. We help our clients:

  • Proactively identify and avoid potential challenges for these often novel therapies
  • Design smart, efficient trials that are both cost-effective and addresses regulatory requirements for patient safety
  • Develop more accurate feasibility assessments and accelerate patient recruitment
  • Adjudicate clinical events or endpoints rapidly and efficiently

Deep and Broad Endocrine/Metabolic Experience

  • Since 1992, Medpace has conducted thousands of endocrine/metabolic trials around the globe
  • Significant involvement in 20 NDA submissions
  • Large-scale multinational trial programs, including in emerging markets
  • Broad compound experience for Type 1 and Type 2 diabetes, major obesity programs, hypercholesterolemia, mixed dyslipidemia, and/or with very high triglycerides

Experience in difficult to recruit populations, including:

  • Narrow HbA1c criteria
  • Concomitant diseases (obesity, hypertension, metabolic disorders)
  • Metformin-only patients

The Medpace Difference for Endocrine-Metabolic Studies

In addition to the Medpace Difference that applies to all of our therapeutic areas, our endocrine-metabolic clients benefit from:
  • Medical and regulatory experts who have helped pioneer many preventative metabolic compounds.
  • Close working relationships with investigators, which leads to more accurate feasibility, better recruitment and improved retention.
  • Operational staff with proven track record of successful retention techniques, lifestyle education, and specific site issues
  • associated with diabetes and obesity trial management.
  • Medpace central labs, located in the U.S., Europe, China and Singapore, offering one of the most extensive selections of metabolic biomarkers for clinical trials.
  • Integrated ECG core lab and clinical pharmacology unit to streamline development.
  • Centralized clinical adjudication services, with electronic adjudication system for more rapid turnaround.